The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 gene

A subset of HER2+ breast cancer patients manifest clinical resistance to trastuzumab. Recently, miR-26a and miR-30b have been identified as trastuzumab response regulators, and their target gene CCNE2 seems to play an important role in resistance to trastuzumab therapy. Cell viability was evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Tormo, Eduardo, Adam-Artigues, Anna, Ballester, Sandra, Pineda, Begoña, Zazo, Sandra, González-Alonso, Paula, Albanell, Joan, Rovira, Ana, Rojo, Federico, Lluch, Ana, Eroles, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264595/
https://www.ncbi.nlm.nih.gov/pubmed/28120942
http://dx.doi.org/10.1038/srep41309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264595/
https://www.ncbi.nlm.nih.gov/pubmed/28120942
http://dx.doi.org/10.1038/srep41309

Ejemplares similares